Financial Tearsheet






Cronos Group is an innovative global cannabinoid company with international production and distribution networks across five continents. The Company is committed to building disruptive intellectual property and establishing an iconic brand portfolio.

Stock Chart

Stock Chart

Stock Quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.

News Releases

28 Feb 23
Cronos Group Reports 2022 Fourth Quarter and Full-Year Results
Consolidated net revenue increased 23% in Full Year 2022 compared to Full Year 2021 ; on a constant currency basis consolidated net revenue increased 28% in Full Year 2022 compared to Full Year 2021 Net revenue in Israel increased 128% in Full Year 2022 compared to Full Year 2021 ; on a constant
14 Feb 23
Cronos Group Inc. to Hold 2022 Fourth Quarter and Full-Year Earnings Conference Call on February 28, 2023
TORONTO, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2022 fourth quarter and full-year earnings conference call on Tuesday, February 28, 2023 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s
08 Feb 23
Spinach® Becomes the Number One Edible Brand in January¹
Spinach ® gummies, known for incredible flavors and quality, are winning with adult consumers in the Canadian market TORONTO, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabinoid company, today announced that its award-winning

SEC Filings

Filing date Description

Statement of changes in beneficial ownership of securities

Statement of changes in beneficial ownership of securities

Statement of changes in beneficial ownership of securities

Events

28 February 2023 at 8:30 AM EST
Cronos Group Full Year and Fourth Quarter 2022 Earnings Conference Call
07 December 2022 at 1:00 PM EST
Stifel Canada’s 3rd Annual Future of Healthcare Conference
07 November 2022 at 8:30 AM EST
Cronos Group Third Quarter 2022 Earnings Conference Call